EMIS's update confirmed the business traded marginally ahead of expectations for 2020, with revenue and adjusted operating profit maintained at similar levels to 2019.
The EMIS Health business maintained market share in all key areas and saw steady underlying growth, helped by the Covid-19-related sale of lower-margin hardware. EMIS Enterprise saw trading gradually improve over the second half of 2020 and the planned launch of the first EMIS-X Analytics solution in the final quarter of the year.
Read the full report
EMIS Group plc published this content on 21 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 January 2021 08:15:07 UTC